Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001837257 | SCV002097770 | uncertain significance | Clark-Baraitser syndrome | 2021-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002542800 | SCV003710185 | likely benign | Inborn genetic diseases | 2022-05-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003434329 | SCV004151584 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | TRIP12: PP2, BP4, BS1 |